Neogenomics (NEO) Current Leases (2010 - 2026)

Neogenomics has reported Current Leases for 17 years, with the latest figure at $4.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 57.01% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (up 57.01% YoY), and the FY2025 full-year result was $4.8 million, up 41.26% from the prior year.
• Current Leases for Q1 2026 stood at $4.8 million, up from $4.8 million in the prior quarter.
• The five-year high for Current Leases was $7.4 million in Q2 2023, with the low at $4000.0 in Q3 2023.
• Historically, Current Leases has averaged $3.7 million across 5 years, with a median of $4.1 million in 2025.
• Annual changes were most pronounced in 2022 — Current Leases tumbled 98.31% — and 2024, when it soared 92800.0%.
• Neogenomics' Current Leases stood at $70000.0 in 2022, then soared by 7914.29% to $5.6 million in 2023, then tumbled by 39.73% to $3.4 million in 2024, then surged by 41.26% to $4.8 million in 2025, then grew by 1.09% to $4.8 million in 2026.
• The last three Current Leases figures came in at $4.8 million (Q1 2026), $4.8 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.